Frontage Labs to expand clinical manufacturing; Teva, Sandoz recall products; Bayer assessing Russia;

> Frontage Labs in Exton, PA, will start early next year on a project to expand its clinical trial manufacturing capacity. Release

> Clondalkin Pharma & Healthcare in Kimbolton, U.K., was fined £12,000 and ordered to pay costs of £1,890 after pleading guilty to violating safety provisions after an employee had two fingers crushed in a printing machine. Story

> Teva Pharmaceutical Industries ($TEVA) is voluntarily recalling nearly 49,000 intrauterine copper contraceptives made by Duramed Pharmaceuticals over sterility issues. Notice

> Sandoz is voluntarily recalling 22,818 bottles of cefpodoxime proxetil tablets because stainless steel particles were found in some. Notice

And Finally... Bayer HealthCare says it is looking at all of its options for local production in Russia, from building a plant to forming partnerships. Story

Editor's note: In the article titled "Hospira plans $120M investment in Kansas facility" published on May 29 we incorrectly said FDA issued a warning letter to the McPherson plant in 2010. The article has been amended to remove the mistake. We regret the error.